This preclinical in vitro study used murine pancreatic cancer cell lines cultured with conditioned media from glial cells. It found that glial cell-derived factors increased cancer cell invasiveness and migration, induced markers of epithelial-to-mesenchymal transition, and increased resistance to the chemotherapy drug gemcitabine.